Cargando…
Prognostic Role of Prolactin-Induced Protein (PIP) in Breast Cancer
Prolactin-inducible protein (PIP), also referred to as gross cystic disease fluid protein 15 (GCDFP-15), has been a trending topic in recent years due to its potential role as a specific marker in breast cancer. PIP binds to aquaporin-5 (AQP5), CD4, actin, fibrinogen, β-tubulin, serum albumin, hydro...
Autores principales: | Sauer, Natalia, Matkowski, Igor, Bodalska, Grażyna, Murawski, Marek, Dzięgiel, Piotr, Calik, Jacek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10527336/ https://www.ncbi.nlm.nih.gov/pubmed/37759471 http://dx.doi.org/10.3390/cells12182252 |
Ejemplares similares
-
Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis
por: Urbaniak, Anna, et al.
Publicado: (2023) -
The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis
por: Clark, J W, et al.
Publicado: (1999) -
Prolactin-Induced Protein (PIP) Regulates Proliferation of Luminal A Type Breast Cancer Cells in an Estrogen-Independent Manner
por: Baniwal, Sanjeev K., et al.
Publicado: (2013) -
Gross Cystic Disease Fluid Protein-15(GCDFP-15)/Prolactin-Inducible Protein (PIP) as Functional Salivary Biomarker for Primary Sjögren’s Syndrome
por: Gallo, A, et al.
Publicado: (2013) -
Tear Proteins Calcium binding protein A4 (S100A4) and Prolactin Induced Protein (PIP) are Potential Biomarkers for Thyroid Eye Disease
por: Chng, Chiaw-Ling, et al.
Publicado: (2018)